Tech Company Financing Transactions

Bellicum Pharmaceuticals Funding Round

On 3/12/2012, Bellicum Pharmaceuticals announced $20 million in Series B investment from Remeditex Ventures and private investors.

Transaction Overview

Announced On
3/12/2012
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors

Remeditex Ventures (Dennis Stone)

Proceeds Purpose
The funding will be used to advance its lead CaspaCIDe and DeCIDe programs through Phase 2 clinical development.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2130 West Holcombe Blvd. 800
Houston, TX 77030
USA
Email Address
Overview
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Profile
Bellicum Pharmaceuticals LinkedIn Company Profile
Social Media
Bellicum Pharmaceuticals Company Twitter Account
Company News
Bellicum Pharmaceuticals News
Facebook
Bellicum Pharmaceuticals on Facebook
YouTube
Bellicum Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Fair
  Rick Fair LinkedIn Profile  Rick Fair Twitter Account  Rick Fair News  Rick Fair on Facebook
VP - Bus. Development
Gregory Naeve
  Gregory Naeve LinkedIn Profile  Gregory Naeve Twitter Account  Gregory Naeve News  Gregory Naeve on Facebook
VP - Finance
Rosie Williams
  Rosie Williams LinkedIn Profile  Rosie Williams Twitter Account  Rosie Williams News  Rosie Williams on Facebook
VP - Manufacturing
Joseph Senesac
  Joseph Senesac LinkedIn Profile  Joseph Senesac Twitter Account  Joseph Senesac News  Joseph Senesac on Facebook
VP - Operations
Alan Smith
  Alan Smith LinkedIn Profile  Alan Smith Twitter Account  Alan Smith News  Alan Smith on Facebook
VP - Product Management
Aaron Foster
  Aaron Foster LinkedIn Profile  Aaron Foster Twitter Account  Aaron Foster News  Aaron Foster on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/12/2012: HemaQuest Pharmaceuticals venture capital transaction
Next: 3/13/2012: Apperian venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary